GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Valuation Rank

C-Rad AB (OSTO:CRAD B) Valuation Rank


View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

C-Rad AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Rad AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Valuation Rank
Comparable Companies
OSTO:BACTI B OSTO:OSSD OSTO:PAX OSTO:SEZI OSTO:MNTC OSTO:BRAIN OSTO:PRO OSTO:SEDANA OSTO:BOUL OSTO:INTEG B ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
0R44:UK 24C:Germany
Address
Sjukhusvagen 12K, Uppsala, SWE, 753 09
Website
https://www.c-rad.com
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa and the rest from Americas and Asia Pacific region.